American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

Why all heart patients should be vaccinated against the flu, COVID-19, RSV
The American College of Cardiology has shared new recommendations highlighting the protective benefits of a variety of vaccines. The new guidance also examines how to speak with patients who are hesitant to be vaccinated.
New Apple Watch Ultra 3 makes early hypertension detection a priority
"This tool empowers patients and clinicians to work together, putting prevention at the center of care," said Ami B. Bhatt, MD, ACC chief innovation officer. "What we really want to do is create patient agency and reach as many people as we can for earlier detection of high blood pressure."
Open-source AI model delivers accurate echocardiography assessments
The algorithm, trained on more than 150,000 TTE studies, can calculate 18 different measurements regularly used in echocardiography
TAVR still a safe option for patients with nickel allergies
More research is still needed, as this study only included data from a small number of patients, but TAVR was not linked to any severe adverse events or allergic reactions.
Exploring the lasting legacy of the STS/ACC TVT Registry
"We're constantly trying to keep our fingers on the pulse of what's happening in the real world," explained Joan Michaels, RN, director of the STS/ACC TVT Registry. "This is not a trial; this is real-world experience."

Video interview with Jaffar Khan, MD, St. Francis Heart Center, explaining tests using IVL in mitral annular calcification (MAC).

Can IVL help cardiologists treat mitral valve disease?

Jaffar Khan, MD, explained his team's work using intravascular lithotripsy balloons in a cadaver heart to break up mitral annular calcification.

Pericarditis: New guidance takes on the diagnosis and management of a challenging heart condition

Pericarditis, inflammation of the pericardium, accounts for approximately 5% of all emergency department evaluations for chest pain. These new recommendations are designed to help guide clinicians through the ins and outs of patient care.

Amy Thompson from Signify Research explains integration of AI into CVIS systems

AI now embedded in nearly every cardiovascular IT system

Artificial intelligence's role in day-to-day patient care continues to grow. What should health systems and cardiology departments be thinking about as they shop for new technologies?

Cardiac amyloidosis ATTR-CM drug promotion at the 2024 American Heart Association meeting.

High cost of cardiac amyloidosis drugs may limit access for low-income patients

"We cannot accept a system where only those with means can benefit from life-changing drugs. We are a wealthy nation that spends trillions on healthcare. We must ensure that income and wealth do not determine access," explained JACC Editor-in-Chief Harlan M. Krumholz, MD.

Karen Joynt Maddox discusses macroeconomic factors pressuring traditional models of cardiac care.

How economic forces are reshaping the future of cardiac care

Karen Joynt Maddox, MD, MPH, explained the many ways cardiology's business models are starting to evolve. She also touched on a number of other topics, including AI and the power of prevention.

Exploring the value of same-day permanent pacemaker implantation after TAVR

Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. New research out of Canada suggests it may make sense in certain scenarios to go straight to the permanent pacemaker.

Widespread use of polypills could prevent up to 72 million heart disease deaths

Targeting high-risk patients with single-pill combination therapies, also known as polypills, could change healthcare on a global scale, according new data published in the Journal of the American College of Cardiology.

Video interview with Allen Taylor, MD, chairman of cardiology at Medstar, who explains use of AI CCTA plaque analysis at Medstar to improve risk assessments.

AI software takes cardiac risk assessments to another level

Allen Taylor, MD, thinks AI-powered plaque evaluations can make a substantial impact on patient care.

American College of Cardiology (ACC)

Why all heart patients should be vaccinated against the flu, COVID-19, RSV

New Apple Watch Ultra 3 makes early hypertension detection a priority

Open-source AI model delivers accurate echocardiography assessments

TAVR still a safe option for patients with nickel allergies

Exploring the lasting legacy of the STS/ACC TVT Registry